Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics
AS Nam, R Chaligne, DA Landau - Nature Reviews Genetics, 2021 - nature.com
Cancer represents an evolutionary process through which growing malignant populations
genetically diversify, leading to tumour progression, relapse and resistance to therapy. In …
genetically diversify, leading to tumour progression, relapse and resistance to therapy. In …
[HTML][HTML] Multiclonal invasion in breast tumors identified by topographic single cell sequencing
Ductal carcinoma in situ (DCIS) is an early-stage breast cancer that infrequently progresses
to invasive ductal carcinoma (IDC). Genomic evolution has been difficult to delineate during …
to invasive ductal carcinoma (IDC). Genomic evolution has been difficult to delineate during …
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
J Chen, YR Kao, D Sun, TI Todorova, D Reynolds… - Nature medicine, 2019 - nature.com
Myelodysplastic syndromes (MDS) frequently progress to acute myeloid leukemia (AML);
however, the cells leading to malignant transformation have not been directly elucidated. As …
however, the cells leading to malignant transformation have not been directly elucidated. As …
Using single-cell multiple omics approaches to resolve tumor heterogeneity
It has become increasingly clear that both normal and cancer tissues are composed of
heterogeneous populations. Genetic variation can be attributed to the downstream effects of …
heterogeneous populations. Genetic variation can be attributed to the downstream effects of …
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes
J Nagasaki, T Inozume, N Sax, R Ariyasu, M Ishikawa… - Cell reports, 2022 - cell.com
PD-1 blockade exerts clinical efficacy against various types of cancer by reinvigorating T
cells that directly attack tumor cells (tumor-specific T cells) in the tumor microenvironment …
cells that directly attack tumor cells (tumor-specific T cells) in the tumor microenvironment …
Joint single cell DNA-seq and RNA-seq of gastric cancer cell lines reveals rules of in vitro evolution
Cancer cell lines are not homogeneous nor are they static in their genetic state and
biological properties. Genetic, transcriptional and phenotypic diversity within cell lines …
biological properties. Genetic, transcriptional and phenotypic diversity within cell lines …
clonealign: statistical integration of independent single-cell RNA and DNA sequencing data from human cancers
Measuring gene expression of tumor clones at single-cell resolution links functional
consequences to somatic alterations. Without scalable methods to simultaneously assay …
consequences to somatic alterations. Without scalable methods to simultaneously assay …
Distinct patterns of clonal evolution drive myelodysplastic syndrome progression to secondary acute myeloid leukemia
T Guess, CR Potts, P Bhat, JA Cartailler, A Brooks… - Blood Cancer …, 2022 - AACR
Clonal evolution in myelodysplastic syndrome (MDS) can result in clinical progression and
secondary acute myeloid leukemia (sAML). To dissect changes in clonal architecture …
secondary acute myeloid leukemia (sAML). To dissect changes in clonal architecture …
Multiomic analysis reveals comprehensive tumor heterogeneity and distinct immune subtypes in multifocal intrahepatic cholangiocarcinoma
S Chen, Y Xie, Y Cai, H Hu, M He, L Liu, C Liao… - Clinical Cancer …, 2022 - AACR
Purpose: Targeted therapy and immunotherapy are transforming the treatment approach for
intrahepatic cholangiocarcinoma (ICC). However, little is known about the intertumor …
intrahepatic cholangiocarcinoma (ICC). However, little is known about the intertumor …
Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor
Single-cell whole-exome sequencing (scWES) is a powerful approach for deciphering
intratumor heterogeneity and identifying cancer drivers. So far, however, simultaneous …
intratumor heterogeneity and identifying cancer drivers. So far, however, simultaneous …